Robert Joseph Ginsberg

Robert Joseph Ginsberg's AcademicInfluence.com Rankings

Philosophy

#7458

World Rank

#10678

Historical Rank

Logic

#4504

World Rank

#5812

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Robert Joseph Ginsberg's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Robert Joseph Ginsberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert Joseph Ginsberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. (1995) (2412)
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. (2002) (1358)
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. (1997) (1345)
Incidence of local recurrence and second primary tumors in resected stage I lung cancer. (1995) (972)
Modern thirty-day operative mortality for surgical resections in lung cancer. (1983) (618)
Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. (1999) (492)
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. (2001) (476)
Thymoma: a multivariate analysis of factors predicting survival. (1995) (379)
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. (1989) (346)
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. (2003) (340)
Esophageal perforation: a continuing challenge. (1992) (337)
Technique of successful lung transplantation in humans. (1987) (307)
Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. (2001) (297)
Lung resection for colorectal metastases. 10-year results. (1992) (275)
Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group (1984) (265)
Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. (1996) (251)
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team. (2000) (248)
Pleurodesis using talc slurry. (1994) (245)
Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. (2002) (238)
Staging and prognostic factors in small cell lung cancer: a consensus report (1989) (227)
Technique of successful clinical double-lung transplantation. (1988) (222)
Proposed revision of the staging classification for esophageal cancer. (1998) (213)
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. (1997) (207)
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. (2010) (197)
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. (1992) (195)
Malignant esophagorespiratory fistula: management options and survival. (1991) (191)
Use of silicone stents in the management of airway problems. (1989) (189)
Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. (1994) (183)
Survival after resection of stage II non-small cell lung cancer. (1992) (178)
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. (1994) (177)
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. (2002) (176)
Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. (1994) (176)
Risk of a right pneumonectomy: role of bronchopleural fistula. (2005) (164)
Significance of metastatic disease in subaortic lymph nodes. (1987) (162)
Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. (1995) (159)
GENERAL THORACIC SURGERY LONG-TERM RESULTS OF LUNG METASTASECTOMY : PROGNOSTIC ANALYSES BASED ON 5206 CASES The International Registry of Lung Metastases (2004) (155)
Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. (2002) (155)
Thymic carcinoma: current staging does not predict prognosis. (1998) (151)
The clamshell incision: an improved approach to bilateral pulmonary and mediastinal tumor. (1994) (149)
A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. (1987) (149)
Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. (2000) (146)
Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. (1991) (145)
Extent of chest wall invasion and survival in patients with lung cancer. (1999) (140)
Primary sarcomas of the mediastinum: results of therapy. (1998) (140)
Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. (2000) (139)
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. (1999) (137)
Experience with single-lung transplantation for pulmonary fibrosis. The Toronto Lung Transplant Group. (1988) (132)
A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study. (1989) (126)
Lobectomy improves ventilatory function in selected patients with severe COPD. (1998) (124)
Pulmonary Metastasectomy for Head and Neck Cancers (1999) (123)
The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. (1982) (121)
Extended cervical mediastinoscopy. (1987) (121)
Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung. (1988) (120)
Predictors of survival in malignant tumors of the sternum. (1996) (115)
Accuracy of lung imaging in metastases with implications for the role of thoracoscopy. (1993) (114)
Effects of diltiazem versus digoxin on dysrhythmias and cardiac function after pneumonectomy. (1997) (111)
Primary bony and cartilaginous sarcomas of chest wall: results of therapy. (1992) (110)
Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. (1994) (107)
Extended cervical mediastinoscopy. A single staging procedure for bronchogenic carcinoma of the left upper lobe. (1987) (106)
New technique for one-lung anesthesia using an endobronchial blocker. (1981) (104)
Surgical treatment for higher stage non-small cell lung cancer. (1992) (104)
Successful treatment of solitary extracranial metastases from non-small cell lung cancer. (1995) (103)
Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. (1997) (103)
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. (2002) (100)
Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. (2000) (99)
Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. (1985) (93)
Management of non-small cell lung cancer with direct mediastinal involvement. (1994) (90)
Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. (1999) (86)
Is there ever a role for salvage operations in limited small-cell lung cancer? (1991) (86)
Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer. (1983) (85)
Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. (1998) (85)
Extragonadal germ cell tumors. A 14‐year Toronto experience (1994) (85)
Current operative morbidity associated with elective surgical resection for lung cancer. (1989) (84)
Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging. (1994) (84)
Open window thoracostomy in the management of postpneumonectomy empyema with or without bronchopleural fistula. (1983) (81)
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. (2000) (80)
Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group. (1993) (79)
Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial. (1996) (78)
The reconstruction of circumferential tracheal defects with a porous prosthesis. An experimental and clinical study using heavy Marlex mesh. (1968) (78)
Circulation of the spinal cord: an important consideration for thoracic surgeons. (2003) (75)
Results of surgical treatment for thymoma. (1984) (74)
A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. (2002) (74)
Evaluation of the mediastinum by invasive techniques. (1987) (74)
Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122. (1996) (73)
Lymph node mapping of esophageal cancer. (1994) (72)
Chest wall resection for locally recurrent breast cancer: is it worthwhile? (2000) (71)
Medical tumors of the chest wall. Solitary plasmacytoma and Ewing's sarcoma. (1993) (71)
RESEKTION VON LUNGENMETASTASEN: LANGZEITRESULTATE PROGNOSTISCHER FAKTOREN AUF DER BASIS VON 5206 FALLEN: THE INTERNATIONAL REGISTRY OF LUNG METASTASES (1999) (70)
NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network. (1996) (69)
Mediastinal lymph node metastases from bronchogenic carcinoma: detection with MR imaging and CT. (1987) (69)
Is there a role for pneumonectomy in pulmonary metastases? International Registry of Lung Metastases. (1999) (68)
Radiotherapy alone for patients with operable carcinoma of the lung. (1985) (67)
[Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases]. (1999) (64)
15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer. (2003) (62)
S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results (2005) (62)
Value of perioperative Doppler echocardiography in patients undergoing major lung resection. (1996) (60)
Vocal cord medialization for unilateral paralysis associated with intrathoracic malignancies. (1996) (51)
Morbidity and mortality after pneumonectomy. (1999) (51)
Precision cautery excision of pulmonary lesions. (1986) (51)
Alternative (muscle-sparing) incisions in thoracic surgery. (1993) (49)
Closure of chronic postpneumonectomy bronchopleural fistula using the transsternal transpericardial approach. (1989) (48)
S9900: Surgery alone or surgery plus induction (ind) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Follow-up on a phase III trial (2007) (47)
Tube drainage of lung abscesses. (1987) (47)
"Incomplete resection" in non-small cell lung cancer: need for a new definition. Canadian Lung Oncology Group. (1998) (46)
Innominate artery rupture. A major complication of tracheal surgery. (1975) (46)
Current management of colorectal metastases to lung. (1998) (45)
Quality-of-life assessment in lung surgery for bronchogenic carcinoma (1991) (44)
Identification of somatostatin receptors in human small cell lung carcinoma (1990) (43)
Prognostic factors in non-small cell lung cancer. (1991) (41)
A new staging proposal for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases. (1998) (41)
The comparison of limited resection to lobectomy for T1N0 non-small cell lung cancer. LCSG 821. (1994) (38)
VATS Port Site Recurrence: A Technique Dependent Problem (2001) (38)
Lung cancer staging: The value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy (1996) (38)
A bronchogenic cyst successfully treated by mediastinoscopy. (1972) (37)
Small-cell lung cancer. (2001) (37)
Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. (2001) (36)
Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? The Lung Cancer Study Group. (1988) (36)
Resection of lung cancer invading the diaphragm. (1997) (35)
Bronchial artery regeneration after radical hilar stripping. (1966) (34)
Editorial: Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas (1996) (34)
Surgery for thymoma. (2001) (33)
Induction therapy for NSCLC: a consensus report (1991) (32)
Multimodality therapy for stage IIIA (N2) lung cancer. An overview. (1993) (31)
Adenovirus vector-mediated gene transfer to regional lymph nodes. (2000) (30)
Limited resection in the treatment of stage I non-small cell lung cancer; an overview. (1989) (29)
A modified Sugiura procedure. (1982) (29)
Phase I dose escalation study using the deep inspiration breath hold technique to safely increase dose to 81 Gy in the treatment of inoperable non-small cell lung cancer (2000) (28)
Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer. (2011) (28)
Esophagectomy for complex benign esophageal disease. (1988) (27)
Patients with T1 N0 non-SCLC lung cancer (1991) (27)
Resection of non-small cell lung cancer: how much and by what route. (1997) (26)
High-flow catheter ventilation during major tracheobronchial reconstruction. (1985) (26)
Continuing controversies in staging NSCLC: an analysis of the revised 1997 staging system. (1998) (26)
Lung cancer surgery: acceptable morbidity and mortality, expected results and quality control. (2002) (25)
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial. (2005) (24)
The role of multimodality therapy in locoregional non-small cell lung cancer. (1997) (24)
Diagnosis of mediastinal masses in pediatric patients using mediastinoscopy and the Chamberlain procedure. (1999) (22)
Cancer treatment in the elderly. (1998) (22)
Function-sparing surgery for desmoid tumors and other low-grade fibrosarcomas involving the brachial plexus. (1998) (21)
NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer. (1993) (21)
Tumors of the diaphragm. (1998) (21)
A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report. (1997) (20)
Thoracoscopy: a cautionary note. (1993) (19)
Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. (1996) (19)
Staging classification committee. (1997) (18)
Surgical treatment of small cell lung cancer. (2003) (16)
Induction therapy for stage III NSCLC: a consensus report. (1994) (16)
Solitary plasmacytoma and Ewing's sarcoma (1993) (16)
Magnetic resonance imaging of the mediastinum. (1986) (16)
Contribution of videothoracoscopy to the management of the cancer patient (1994) (15)
Management of the recalcitrant postpneumonectomy bronchopleural fistula: the transsternal transpericardial approach. (2001) (14)
Technique for shortening angioplasty guide catheter length when therapeutic catheter fails to reach target stenosis. (1993) (14)
The solitary pulmonary nodule: can we afford to watch and wait? (2003) (13)
Thoracic Surgery, 2nd Edition (2004) (13)
Lung Cancer Surgical Practice Guidelines (1997) (13)
Neoadjuvant (induction) treatment for non-small cell lung cancer. (1995) (13)
Direct and indirect myocardial revascularization: follow-up and appraisal. (1970) (12)
Operation for small cell lung cancer--where are we? (1990) (11)
The costs of cancer therapy. (1990) (11)
Limits and perspectives of surgical resection for non-small cell lung cancer (1991) (11)
5. New approaches to the management of flail chest. (1977) (11)
The multimodality treatment of stage III A/B non-small cell lung cancer. The role of surgery, radiation, and chemotherapy. (1997) (10)
Carcinoembryonic antigen, arginine vasopressin and calcitonin as markers of early small-cell lung cancer relapse. (1989) (10)
Surgery and small cell lung cancer — an overview (1989) (10)
Mediastinal germ cell tumors: the role of surgery. (1992) (10)
Management of the pneumothorax and barotrauma. (1992) (10)
Small cell lung cancer: how should we treat it? What is it? (2000) (10)
The role of preoperative surgical staging in left upper lobe tumors. (1994) (10)
Surgical approach to non-small cell lung cancer stage IIIA. (1990) (9)
Final report of the 70.2 GY and 75.6 GY dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer (1998) (9)
Induction chemotherapy employing dose‐intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma (1999) (8)
Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience (1993) (8)
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2). (1995) (7)
Pre-operative and post-operative treatments in stage III NSCLC. (1994) (7)
Lung cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines. (1997) (7)
38 Neoadjuvant chemotherapy plus concurrent chemotherapy and high dose radiation for squamous cell cancer of the esophagus — A preliminary analysis of intergroup trial 0122 (ECOG PE-289/RTOG 9012) (1995) (6)
Heterogeneous reactions : III. Evidence for an alkoxide induced 1,2-hydride shift from silicon to carbon under heterogeneous gas/solid phase reaction (1977) (6)
The Lung Cancer Study Group Experience: Adjuvant Therapy for Resectable Lung Cancer (1986) (5)
The role of induction therapy and surgery for stage IIIA lung cancer. (1995) (5)
Multimodality therapy for non-small cell lung cancer: the role of surgery (1993) (5)
Surgery in small cell lung cancer: a consensus report (1989) (5)
Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team. (1997) (5)
Future directions in surgery for lung cancer (1993) (5)
The Sugiura procedure for bleeding esophageal varices: a modification. (1982) (5)
Esophageal fistula (2020) (5)
Tube thoracostomy drainage. An alternative in the management of giant bullae? (1988) (4)
Haemodynamic effects of propofol. (1993) (4)
Esophageal cancer surgical practice guidelines. Esophageal Cancer Practice Guideline Committee. (1997) (4)
Morbidity and mortality for pulmonary resections in lung cancer after induction treatment (2000) (4)
O-201 A phase II trial of induction chemotherapy followed by extrapleural pneumonectomy and high-dose hemithoracic radiation for malignant pleural mesothelioma (2003) (4)
Multimodality treatment of resectable non small-cell lung cancer. (2000) (4)
Invasive and noninvasive techniques of staging in potentially operable lung cancer. (1990) (4)
Esophageal Cancer Surgical Practice Guidelines (1997) (3)
Options in the surgical treatment of esophageal carcinoma. (1994) (3)
Endobronchial carbon-dioxide laser therapy. (1986) (3)
Lymph nod involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas. (1996) (3)
Extended resection for higher-stage non-small-cell lung cancer (1993) (3)
Surgical treatment of stage IIIa non-small cell lung cancer (1992) (3)
Surgical considerations after preoperative treatment. (1994) (3)
Resection of a superior sulcus tumor. (1995) (3)
Toxicity and pharmacokinetics of isolated lung perfusion with cisplatin in rat. (2001) (2)
O-63 Brain metastases as the initial site of failure in locally advanced non-small cell lung cancer treated with combined modality therapy: Implications for prophylactic cranial irradiation (2003) (2)
Carinal Resection and Sleeve Pneumonectomy Using a Transsternal Approach (1998) (2)
327 Phase II trial of induction paclitaxel/carboplatin (PC) in early stage (T2NO, T1-2N1, and selected T3NO-1) non-small cell lung cancer (NSCLC) (1997) (2)
Fourth World Conference on lung cancer August 25–30, 1985 Toronto, Canada (1986) (2)
Mediastinoscopy re-examined. (1991) (2)
New Examples of tris Organosilylboranes (1976) (2)
One year follow-up reveals no difference in quality of life between high dose and conventional dose radiation: a quality of life assessment of RTOG 94-05 (2001) (2)
Diagnostic and staging procedures in non-small cell lung cancer. (1990) (1)
Group organizational structure (2001) (1)
The esophagus: Medical and surgical management (1989) (1)
2152 Phase II trial of combined surgical resection, high dose rate intraoperative radiation therapy, and external beam radiotherapy for malignant pleural mesothelioma (1997) (1)
Esophageal cancer. Early efforts and proposals of the LCSG. (1994) (1)
Anesthesia for repair of a pulmonary artery sling. (1992) (1)
Controversies in staging non-small cell lung cancer (1997) (1)
P-253 Anemia as a prognostic factor in induction chemotherapy for stage IIIA N2 non small cell lung cancer (NSCLC) (2003) (1)
Surgical Approaches to Locally Advanced Non—Small-Cell Lung Cancer (1997) (1)
Intravascular ultrasound evaluation of interventional procedures: Comparison with fiberoptic angioscopy (1990) (1)
Anaphylactoid reactions to radio-opaque contrast media. (2002) (1)
Surgical resection for non-small cell lung cancer—the impact of chemotherapy (1997) (1)
Lung Perfusion for Treatment of Metastatic Sarcoma to the Lungs (2000) (1)
THE MULTIMODALITY TREATMENT OF STAGE I11 A/B CANCER NON-SMALL CELL LUNG The Role of Surgery, Radiation, and Chemotherapy (1997) (1)
Neoadjuvant therapy of esophageal cancer. (1997) (0)
Staging and Surgical Treatment for Non-Small Cell Lung Cancer (1991) (0)
Long-Term Resul ts of Combined-Modal i ty Therapy in Resectable Non – Smal l-Cel l Lung Cancer (2002) (0)
Is there a role for pneumonectomy in pulmonary metastases? 1 1 For a listing of members of the Inter (1999) (0)
This house believes that non-surgical treatment is standard treatment in the management of patients withclinical N2 non-small lung cancer (1994) (0)
Lung cancer : atlas of clinical oncology (2002) (0)
Early Detected Lung Cancer : Finding an Appropriate Treatment (0)
NEW EXAMPLES OF TRIS-ORGANOSILYLBORANES (1977) (0)
Gibbon's Surgery of the Chest. Fourth Edition (1984) (0)
ATRIAL FIBRILLATION FOLLOWING THORACIC SURGERY: ROLE OF CALCIUM CHANNEL ACTIVATION (1999) (0)
A canine with a problem: a case report. (1991) (0)
Undifferentiated Carcinoma of the Mediastinum (1995) (0)
Gastric cooling--a clinical study. (1965) (0)
Report from Hiroshima (1) (1987) (0)
The year book of thoracic and cardiovascular surgery (1997) (0)
Whole B ody 18 FDG-PET a nd t he R esponse o f E sophageal Cancer t o I nduction T herapy: R esults o f a P rospective T rial (2003) (0)
Thoracoscopic Management of Chest Neoplasms (1994) (0)
Surgical oncology committee (2001) (0)
LUNG CANCER SURGICAL PRACTICE GUIDELINES : SCOPE AND FORMAT OF GUIDELINES (1997) (0)
Esophageal, gastric, and small intestine. (1994) (0)
Operation for Small Cell Lung Cancer-Where (1990) (0)
O-100 The risk of right pneumonectomy: the role of bronchopleural fistula (2003) (0)
Procedure and heat removal system of a nuclear reactor containment in alternative boiling water (2013) (0)
Report from Hiroshima (2) (1987) (0)
Commentary (Ginsberg): Surgical Staging of Lung Cancer (1999) (0)
European School of Oncology First Euro-American Forum Treatment on Lung Cancer (2003) (0)
P-716 Importance of nodal status and impact of mediastinoscopy in preoperative staging of patients with malignant pleural mesothelioma (2003) (0)
ESOPHAGEAL CANCER SURGICAL PRACTICE GUIDELINES : SCOPE AND FORMAT OF GUIDELINES (1997) (0)
Multidisciplinary Care of Lung Cancer Patients , Part I THE MULTIMODALITY TREATMENT OF STAGE III A / B NON-SMALL CELL LUNG CANCER The Role of Surgery , Radiation , and Chemotherapy (2002) (0)
HETEROGENEOUS REACTIONS. III. EVIDENCE FOR AN ALKOXIDE INDUCED 1,2-HYDRIDE SHIFT FROM SILICON TO CARBON UNDER HETEROGENEOUS GAS SOLID PHASE REACTION (1977) (0)
Commentary (Ginsberg): Diffuse Malignant Mesothelioma of the Pleural Space and Its Management (2002) (0)
Commentary (Downey/Ginsberg): Surgical Treatment of Metastatic Pulmonary Soft-Tissue Sarcoma (2000) (0)
Combined-Modal i ty Therapy for Esophageal Cancer : High-Dose Versus Standard-Dose Radiat ion Therapy (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert Joseph Ginsberg?

Robert Joseph Ginsberg is affiliated with the following schools:

University of Toronto